Ojo 2003 reported higher risks of CKD following liver transplantation among those patients who received Calcineurin inhibitors.
Ojo 2003 reportó un mayor riesgo de enfermedad renal crónica postrasplante hepático en aquellos pacientes que recibieron inhibidores de calcineurina.